Modulation of Therapeutic Response
Modulation of Therapeutic Response
批准号:
7735357
负责人:
JAMES B MITCHELL
金额:
$44.88万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AttentionBiological AssayCell CycleCellsClinicalClinical DataClinical TrialsDNA RepairDataDoseEvaluationFibrosisGenesGoalsH2AFX geneHead and Neck CancerHumanIn VitroInterferonsIonizing radiationKnockout MiceLate EffectsLoratadineMitosisModificationMolecularMolecular ProfilingMusNormal tissue morphologyPathway interactionsPhysiologyProcessRadiationRadiation Induced DNA DamageRadiation OncologyRadiation induced damageRadiation-Induced Gene ExpressionRadiation-Protective AgentsResearchResearch DesignResistanceSignal TransductionSolid NeoplasmTGF Beta Signaling PathwayTherapeuticToxic effectTransforming Growth Factor betaTranslatingTumor-Associated ProcessWorkcancer therapychemotherapygene inductionhuman H2AX proteinimprovedin vivoinhibitor/antagonistinterestkinase inhibitorneoplastic cellnoveloral mucositispre-clinicalpre-clinical researchpreclinical studypregna-4,17-diene-3,16-dioneradiation effectreceptorrepairedresponsesoft tissuetempoltumor
中文摘要
为了改善癌症, 在治疗方面,相当多的注意力已经放在辐射损伤的修饰上。的 各种化疗和/或分子靶向剂与放射的相互作用 正在研究是否可以使肿瘤更敏感或使正常组织更耐药 到放射治疗中心目标是确定将导致净 治疗增益,从而改善癌症的放射治疗。该项目的一个目标是 定义和更好地理解肿瘤生理学的这些方面,包括细胞和 分子过程和肿瘤微环境对治疗反应的影响。两 已经完成的独立研究表明,辐射诱导的基因表达 对于体外暴露的细胞与作为一种生长因子生长的相同细胞, 体内实体瘤进一步强调了肿瘤微环境对肿瘤细胞增殖的影响。 辐射反应此外,我们已经表明,多部分辐射输送导致 比单剂量放射治疗更强大的基因诱导,特别是 干扰素相关基因,包括STAT-1。我们将尝试调节这些基因, 确定它们对多分割放射治疗的影响。加强能力, 肿瘤对辐射的反应,在给定的治疗中不增强正常组织 场是可取的。我们最近表明,氯雷他定和guggulsterone会增强肿瘤 体外细胞辐射反应。初步机制研究表明,氯雷他定 在细胞周期中施加G2/M阻滞(细胞周期的G2/M期是非常放射敏感的), guggulsterone,它似乎干扰辐射诱导的DNA损伤修复。评价 两种药物联合放射治疗荷瘤小鼠的研究正在进行中。我们 还评估了另一种分子靶向药物,即Chk-1抑制剂。此代理 在体外和体内提供肿瘤细胞的相当大的辐射增强, 很少或没有正常组织毒性。工作假设是代理废除了 正常辐射诱导的细胞周期G2期延迟,从而增强辐射反应 因为辐射损伤修复不完全我们还表明,这个代理人直接 使用H2 AX测定抑制辐射诱导的损伤修复。相对于正常组织 在对辐射的反应中,众所周知TGF β信号通路是一个主要的 辐射诱导的迟发效应(纤维化)。我们之前的研究表明, 缺乏TGF β信号传导(Smad 3敲除小鼠--TGF β信号传导中的下游信号传导中间体)。 TGF β途径)在用高剂量辐射治疗时对纤维化具有抗性。最近 使用TGF β 1型受体激酶抑制剂的小鼠正常组织研究显示, 辐射引起的软组织纤维化显著减少。这种药物可以阻断TGF β 信号通路和目前的研究集中在确认这种药物影响TGF 体内的β信号。最后,我们有初步的临床前数据表明, 氮氧化物,Tempol防止辐射引起的口腔粘膜炎。口腔粘膜炎是一种 头颈部癌症放射治疗的常见毒性。的目标 这些临床前研究是为了获得足够的疗效数据, 用于人体放射肿瘤临床试验。
英文摘要
Modulation of Therapeutic Response Summary In the interest of improving cancer treatment, considerable attention has been placed on the modification of radiation damage. The interaction of a variety of chemotherapy and/or molecularly targeted agents with radiation is under study to determine if tumors can be made more sensitive or normal tissues more resistant to radiation treatment. The central aim is to identify approaches that will result in a net therapeutic gain, thus improving cancer treatment with radiation. One goal of the project is to define and better understand those aspects of tumor physiology, including cellular and molecular processes and the influence of the tumor microenvironment on treatment response. Two independent studies have been completed showing that radiation-induced gene expression profiles differ significantly for cells exposed in vitro versus the same cells growing as a solid tumor in vivo further underscoring the influence of the tumor microenvironment on the radiation response. Further we have shown that multi-fraction radiation delivery results in a more robust induction of genes than single dose radiation treatment, in particular the interferon-related genes including STAT-1. We will attempt to modulate these genes to determine their influence on multi-fraction radiation treatment. The ability to enhance the response of the tumor to radiation, without enhancing normal tissue within a given treatment field is desirable. We have recently shown that loratadine and guggulsterone enhance tumor cell radiation response in vitro. Preliminary mechanistic studies indicate that loratadine imposes a G2/M block in cell cycle (G2/M phases of the cell cycle are very radiosensitive) and guggulsterone, which appears to interfere with radiation-induced DNA damage repair. Evaluation of both agents in combination with radiation in tumor bearing mice is currently underway. We have also evaluated another molecularly targeted agent, which is a Chk-1 inhibitor. This agent provides considerable radiation enhancement of tumor cells in vitro and in vivo with very little to no normal tissue toxicity. The working hypothesis is that the agent abrogates the normal radiation-induced delay in G2 of the cell cycle, thus enhancing the radiation response because of incomplete repair of radiation damage. We have also shown that this agent directly inhibits radiation-induced damage repair using the H2AX assay. With respect to normal tissue response to radiation, it is widely known that the TGF beta signaling pathway is a major player in radiation-induced late effects (fibrosis). Our previous studies have shown that mice deficient in TGF beta signaling (Smad3 knock-out mice-downstream signaling intermediate in the TGF beta pathway) are resistant to fibrosis when treated with high dose radiation. Recent mouse normal tissue studies using a TGF beta type 1 receptor kinase inhibitor have shown marked reduction in radiation-induced soft tissue fibrosis. This agent blocks the TGF beta signaling pathway and current studies are centered in confirming that this agent impacts TGF beta signaling in vivo. Lastly we have preliminary pre-clinical data suggesting that the nitroxide, Tempol protects against radiation-induced oral mucositis. Oral mucositis is a common toxicity associated with the radiation treatment of head and neck cancers. The goal of these pre-clinical studies is to gain enough efficacy data to introduce these experimental agents into human radiation oncology clinical trials.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Evaluation of hybridization conditions for spotted oligonucleotide-based DNA microarrays.
基于斑点寡核苷酸的 DNA 微阵列杂交条件的评估。
DOI:
10.1385/mb:29:3:221
发表时间:
2005
期刊:
Molecular biotechnology
影响因子:
2.6
作者:
[Tsai,Mong-Hsun, Yan,Hailing, Chen,Xi, Chandramouli,GVR, Zhao,Shuping, Coffin,Deborah, Coleman,CNorman, Mitchell,JamesB, Chuang,EricY]
通讯作者:
Chuang,EricY
Influence of proton T1 on oxymetry using Overhauser enhanced magnetic resonance imaging.
使用 Overhauser 增强磁共振成像质子 T1 对血氧测定的影响。
DOI:
10.1002/mrm.20564
发表时间:
2005
期刊:
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine
影响因子:
--
作者:
[Matsumoto,Shingo, Utsumi,Hideo, Aravalluvan,Thirumaran, Matsumoto,Ken-Ichiro, Matsumoto,Atsuko, Devasahayam,Nallathamby, Sowers,AnastasiaL, Mitchell,JamesB, Subramanian,Sankaran, Krishna,MuraliC]
通讯作者:
Krishna,MuraliC
The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography.
使用[64Cu]Cu-ATSM或[18F]氟罗米索尼唑正电子发射断层扫描观察肿瘤氧合对小鼠鳞状细胞癌缺氧成像的影响。
DOI:
--
发表时间:
2007
期刊:
International journal of oncology
影响因子:
5.2
作者:
[Matsumoto,Ken-Ichiro, Szajek,Lawrence, Krishna,MuraliC, Cook,JohnA, Seidel,Jurgen, Grimes,Kelly, Carson,Joann, Sowers,AnastasiaL, English,Sean, Green,MichaelV, Bacharach,StephenL, Eckelman,WilliamC, Mitchell,JamesB]
通讯作者:
Mitchell,JamesB
DOI:
10.1186/1748-717x-2-19
发表时间:
2007-05-31
期刊:
Radiation oncology (London, England)
影响因子:
--
作者:
[Simone NL, Soule BP, Gerber L, Augustine E, Smith S, Altemus RM, Mitchell JB, Camphausen KA]
通讯作者:
Camphausen KA
DOI:
10.1093/hmg/ddh189
发表时间:
2004-08
期刊:
Human molecular genetics
影响因子:
3.5
作者:
[R. Schubert;Laura R. Erker;C. Barlow;H. Yakushiji;D. Larson;A. Russo;James B. Mitchell;A. Wynshaw-Boris]
通讯作者:
R. Schubert;Laura R. Erker;C. Barlow;H. Yakushiji;D. Larson;A. Russo;James B. Mitchell;A. Wynshaw-Boris
Modulation of Therapeutic Response
-
批准号:6947107
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Radiolysis, Photolysis, Sonolysis and Sonoprotection of
-
批准号:7331390
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:7594762
-
项目类别:
-
资助金额:$63.51万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
NITROXIDES AS PROTECTORS AGAINST OXIDATIVE STRESS
-
批准号:6290749
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:7292012
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7292006
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7331383
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7594757
-
项目类别:
-
资助金额:$63.51万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:6558297
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:6558332
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:7066825
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:6756256
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Modulation of Therapeutic Response
-
批准号:6433342
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:6756263
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:7735362
-
项目类别:
-
资助金额:$44.88万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
MODULATION OF THERAPEUTIC RESPONSE
-
批准号:6290743
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:6433348
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES B MITCHELL
-
依托单位:
海外基金